US Patent Issued to Case Western Reserve University on Jan. 13 for "Compositions and methods for treating CD40-mediated diseases" (Ohio Inventor)

ALEXANDRIA, Va., Jan. 13 -- United States Patent no. 12,522,633, issued on Jan. 13, was assigned to Case Western Reserve University (Cleveland).

"Compositions and methods for treating CD40-mediated diseases" was invented by Carlos Subauste (Shaker Heights, Ohio).

According to the abstract* released by the U.S. Patent & Trademark Office: "A cell-penetrating peptide includes a membrane transduction domain linked to a CD40-TRAF2,3 blocking peptide that includes an amino acid sequence substantially identical to the amino acid sequence of the TRAF2,3 binding domain to CD40 or a retro-inverso amino acid sequence thereof."

The patent was filed on April 2, 2021, under Application No. 17/221,182.

*For further information, including images, chart...